Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis

Daojun Lv1,2, Shengren Cen2, Shuxin Yang2,3

  • 1Department of Urology, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

Insights

Circular RNAs are key in cancer. This study found hsa_circ_0063329 inhibits prostate cancer (PCa) progression by regulating miR-605-5p and TGIF2, offering a potential new PCa treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are critical regulators in various cancers.
  • The specific roles and mechanisms of circRNAs in prostate cancer (PCa) progression and metastasis are not fully understood.

Purpose of the Study:

  • To identify differentially expressed circRNAs in PCa.
  • To elucidate the functional role and molecular mechanism of hsa_circ_0063329 in PCa proliferation and metastasis.

Main Methods:

  • CircRNA microarray analysis to identify differentially expressed circRNAs.
  • In vitro and in vivo functional assays to assess the role of hsa_circ_0063329.
  • Bioinformatics, RNA pulldown, RNA-seq, and dual-luciferase reporter assays to determine the underlying molecular mechanism.

Main Results:

  • Hsa_circ_0063329 was found to be significantly downregulated in PCa.
  • Overexpression of hsa_circ_0063329 inhibited PCa cell progression, while its silencing promoted it.
  • Hsa_circ_0063329 acts as a sponge for miR-605-5p, leading to the derepression of TG-interacting factor 2 (TGIF2) and inactivation of the TGF-β pathway.

Conclusions:

  • Hsa_circ_0063329 inhibits PCa proliferation and metastasis through the miR-605-5p/TGIF2 axis.
  • Targeting hsa_circ_0063329 presents a potential therapeutic strategy for aggressive PCa.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K